Compare MAPS & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAPS | CPIX |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | 449 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.7M | 73.6M |
| IPO Year | N/A | 2007 |
| Metric | MAPS | CPIX |
|---|---|---|
| Price | $0.64 | $3.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.61 | N/A |
| AVG Volume (30 Days) | ★ 686.2K | 98.6K |
| Earning Date | 03-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.17 | N/A |
| P/E Ratio | $9.75 | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $0.60 | $1.85 |
| 52 Week High | $1.36 | $6.27 |
| Indicator | MAPS | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 44.29 |
| Support Level | N/A | $2.95 |
| Resistance Level | $0.88 | $3.69 |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 16.07 | 65.97 |
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.